280 related articles for article (PubMed ID: 34212338)
1. GEIS-SEHOP clinical practice guidelines for the treatment of rhabdomyosarcoma.
Gallego S; Bernabeu D; Garrido-Pontnou M; Guillen G; Hindi N; Juan-Ribelles A; Márquez C; Mata C; Orcajo J; Ramírez G; Ramos M; Romagosa C; Ruano D; Rubio P; Vergés R; Valverde C;
Clin Transl Oncol; 2021 Dec; 23(12):2460-2473. PubMed ID: 34212338
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
3. Pediatric rhabdomyosarcoma in Morocco.
Hessissen L; Kanouni L; Kili A; Nachef MN; El Khorassani M; Benjaafar N; Khattab M; El Gueddari Bel K
Pediatr Blood Cancer; 2010 Jan; 54(1):25-8. PubMed ID: 19746454
[TBL] [Abstract][Full Text] [Related]
4. Role of
Mercolini F; Zucchetta P; Jehanno N; Corradini N; Van Rijn RR; Rogers T; Cameron A; Scarzello G; Coppadoro B; Minard-Colin V; Gallego S; Chisholm J; Merks JH; Bisogno G
Eur J Cancer; 2021 Sep; 155():155-162. PubMed ID: 34385068
[TBL] [Abstract][Full Text] [Related]
5. Current Treatment of Pediatric Bladder and Prostate Rhabdomyosarcoma.
Saltzman AF; Cost NG
Curr Urol Rep; 2018 Feb; 19(1):11. PubMed ID: 29468476
[TBL] [Abstract][Full Text] [Related]
6. Metabolic response as assessed by
Harrison DJ; Chi YY; Tian J; Hingorani P; Mascarenhas L; McCowage GB; Weigel BJ; Venkatramani R; Wolden SL; Yock TI; Rodeberg DA; Hayes-Jordan AA; Teot LA; Spunt SL; Meyer WH; Hawkins DS; Shulkin BL; Parisi MT
Cancer Med; 2021 Feb; 10(3):857-866. PubMed ID: 33340280
[TBL] [Abstract][Full Text] [Related]
7. 18F FDG PET-CT Super scan: Paediatric Rhabdomyosarcoma.
Saeed H; Hassan A; Saeed H; Gill SM
J Pak Med Assoc; 2022 Sep; 72(9):1880-1881. PubMed ID: 36281001
[TBL] [Abstract][Full Text] [Related]
8. Soft tissue sarcoma in children: prognosis and management.
Koscielniak E; Morgan M; Treuner J
Paediatr Drugs; 2002; 4(1):21-8. PubMed ID: 11817983
[TBL] [Abstract][Full Text] [Related]
9. Clinical Study on Female Genital Tract Rhabdomyosarcoma in Childhood: Changes During 20 Years in One Center.
Yang J; Yang J; Yu M; Yuan Z; Cao D; Keng S
Int J Gynecol Cancer; 2017 Feb; 27(2):311-314. PubMed ID: 27870705
[TBL] [Abstract][Full Text] [Related]
10. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.
Raney RB; Anderson JR; Barr FG; Donaldson SS; Pappo AS; Qualman SJ; Wiener ES; Maurer HM; Crist WM
J Pediatr Hematol Oncol; 2001 May; 23(4):215-20. PubMed ID: 11846299
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT is useful in initial staging, restaging for pediatric rhabdomyosarcoma.
Dong Y; Zhang X; Wang S; Chen S; Ma C
Q J Nucl Med Mol Imaging; 2017 Dec; 61(4):438-446. PubMed ID: 25996974
[TBL] [Abstract][Full Text] [Related]
12. Functional image in soft tissue sarcomas: An update of the indications of
Rodríguez-Alfonso B; Simó-Perdigó M; Orcajo Rincón J
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):233-243. PubMed ID: 32616457
[TBL] [Abstract][Full Text] [Related]
13. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.
Wolden SL; Anderson JR; Crist WM; Breneman JC; Wharam MD; Wiener ES; Qualman SJ; Donaldson SS
J Clin Oncol; 1999 Nov; 17(11):3468-75. PubMed ID: 10550144
[TBL] [Abstract][Full Text] [Related]
14. Additional Benefit of F-18 FDG PET/CT in the staging and follow-up of pediatric rhabdomyosarcoma.
Ricard F; Cimarelli S; Deshayes E; Mognetti T; Thiesse P; Giammarile F
Clin Nucl Med; 2011 Aug; 36(8):672-7. PubMed ID: 21716019
[TBL] [Abstract][Full Text] [Related]
15. Future directions in risk stratification and therapy for advanced pediatric genitourinary rhabdomyosarcoma.
Harel M; Ferrer FA; Shapiro LH; Makari JH
Urol Oncol; 2016 Feb; 34(2):103-15. PubMed ID: 26519985
[TBL] [Abstract][Full Text] [Related]
16. Long-term results in children with head and neck rhabdomyosarcoma: A report from the Italian Soft Tissue Sarcoma Committee.
Affinita MC; Ferrari A; Milano GM; Scarzello G; De Leonardis F; Coccoli L; Pericoli R; Basso E; Zanetti I; Scagnellato A; Bisogno G
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115716
[TBL] [Abstract][Full Text] [Related]
17. Rhabdomyosarcoma: the experience of the pediatric unit of Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine (NEMROCK) (from January 1992 to January 2001).
Abd El-Aal HH; Habib EE; Mishrif MM
J Egypt Natl Canc Inst; 2006 Mar; 18(1):51-60. PubMed ID: 17237856
[TBL] [Abstract][Full Text] [Related]
18. Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas.
Ruymann FB; Grovas AC
Cancer Invest; 2000; 18(3):223-41. PubMed ID: 10754991
[TBL] [Abstract][Full Text] [Related]
19. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Meza JL; Anderson J; Pappo AS; Meyer WH;
J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
[TBL] [Abstract][Full Text] [Related]
20. Imaging in rhabdomyosarcoma: a patient journey.
de Vries ISA; van Ewijk R; Adriaansen LME; Bohte AE; Braat AJAT; Fajardo RD; Hiemcke-Jiwa LS; Hol MLF; Ter Horst SAJ; de Keizer B; Knops RRG; Meister MT; Schoot RA; Smeele LE; van Scheltinga ST; Vaarwerk B; Merks JHM; van Rijn RR
Pediatr Radiol; 2023 Apr; 53(4):788-812. PubMed ID: 36843091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
